IGC

IGC PHARMA INC

IGC·45408X308·US·Common Stock·Healthcare - Biotechnology

IGC (IGC PHARMA INC) is held by 20 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($274,440), VANGUARD CAPITAL MANAGEMENT LLC ($188,949), BlackRock, Inc. ($185,099). Net institutional sentiment: Mixed.

20
Holders
Avg rating(5 Elite)
$1.1M
Total Value
59% (23)
Fund Consensus
10 buying - 7 selling

No verdict yet — fewer than 2 funds hold IGC.

13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1M(+21.3%)$274,4400.0%-60.10%
19
New
718,436$188,9490.0%-6.90%
35
Unchanged
703,798$185,0990.0%-22.86%
0
Decreased
483,975(-47.4%)$127,2850.0%-34.94%
0
New
415,888$109,3790.0%-6.90%
33
Unchanged
200,799$52,8100.0%-13.74%
0
Decreased
122,595(-20.9%)$32,2420.0%-7.72%
0
Unchanged
113,407$29,8260.0%-69.33%
0
Unchanged
65,541$17,2370.0%-22.86%
0
Increased
50,648(+78.8%)$13,3200.0%-18.99%
27
Unchanged
43,400$11,4140.0%-35.71%
0
Unchanged
36,667$9,6430.0%-63.47%
0
Increased
35,118(+98.3%)$9,2360.0%-16.20%
18
Increased
33,848(+1.5%)$8,9000.0%-34.03%
12
New
14,944$3,9300.0%-6.90%
22
New
10,000$2,6300.0%-6.90%
19
Decreased
8,097(-59.3%)$2,1290.0%-5.13%
0
Decreased
3,762(-47.7%)$9890.0%-57.36%
0
Increased
101(+1.0%)$270.0%-35.51%
8
New
23,233$60.0%-6.90%
15

Showing 1-20 of 23

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used